Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1998 Aug;65(2):225–232. doi: 10.1136/jnnp.65.2.225

Sleep and neuromuscular disease: bilevel positive airway pressure by nasal mask as a treatment for sleep disordered breathing in patients with neuromuscular disease

C Guilleminault 1, P Philip 1, A Robinson 1
PMCID: PMC2170188  PMID: 9703177

Abstract

OBJECTIVE—Investigation of the therapeutic effects of bilevel positive airway pressure delivered by nasal mask in patients with neuromuscular disease.
METHODS—20 patients with neuromuscular disease were evaluated for symptoms of nocturnal sleep disruption. These symptoms included daytime tiredness, fatigue, sleepiness, and complaints of insomnia. The patients were studied with nocturnal polysomnograms and daytime multiple sleep latency tests (MSLT). Their immediate and long term responses to bilevel positive airway pressure were also investigated. The study took place at the Stanford University Sleep Disorders Clinic. Some of the polygraphic evaluations were performed with portable equipment in the patients' homes. The reported population comprised 20 patients, all of whom had progressive neuromuscular disease. Five of the patients were women. Four patients had muscular dystrophy, six had myotonic dystrophy, and two patients each had mitochondrial myopathy and glycogen storage disease. Two patients had post-traumatic lesions, one bulbar and the other phrenic. The remaining patients had vascular myopathy, unclassified myopathy, syringomyelia, and slow evolving spinocerebellar degeneration.
RESULTS—19 of the 20 patients accepted some form of non-invasive ventilation. All but one of these were initially maintained on bilevel positive airway pressure spontaneous (S) mode, although one patient required a switch to the timed (T) mode within a year. The mean expiratory positive airway pressure (EPAP) used was 4.5 with a range of 4 to 5 cm H2O. The mean inspiratory positive airway pressure (IPAP) was 11.5, range 9 to 14 cm H2O. Before treatment the MSLTs were ⩽ 8 minutes in 11 of the patients. The overall mean score was 8.2 (SD) 1.3 minutes. After long term treatment the mean MSLT was 12.5 (SD 2) minutes and the mean ESS score was 7 (SD 3). During the mean 3.5 years of follow up, three patients needed supplemental oxygen at a flow of 0.5 to 1.0 l/min bled into their masks. Three patients with myotonic dystrophy presented continued daytime somnolence despite apparent adequate treatment of their sleep disordered breathing. This required the addition of stimulant medication to their regimen. During this time three additional subjects had to be switched to nasal mask intermittent positive pressure ventilation delivered by traditional volume cycled home ventilator (volume controlled NIPPV).
CONCLUSIONS—Bilevel positive airway pressure delivered by nasal mask may be used successfully to treat sleep disordered breathing associated with neuromuscular disease. This device can be employed to assist nocturnal ventilation by either the spontaneous or timed mode. In the United States it is less expensive and easier to institute than volume controlled NIPPV and may be as efficacious as this mode if close surveillance and regular re-evaluation of the patient's status is maintained.



Full Text

The Full Text of this article is available as a PDF (127.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbé F., Quera-Salva M. A., de Lattre J., Gajdos P., Agustí A. G. Long-term effects of nasal intermittent positive-pressure ventilation on pulmonary function and sleep architecture in patients with neuromuscular diseases. Chest. 1996 Nov;110(5):1179–1183. doi: 10.1378/chest.110.5.1179. [DOI] [PubMed] [Google Scholar]
  2. Branthwaite M. A. Assisted ventilation 6. Non-invasive and domiciliary ventilation: positive pressure techniques. Thorax. 1991 Mar;46(3):208–212. doi: 10.1136/thx.46.3.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carroll N., Branthwaite M. A. Control of nocturnal hypoventilation by nasal intermittent positive pressure ventilation. Thorax. 1988 May;43(5):349–353. doi: 10.1136/thx.43.5.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carskadon M. A., Dement W. C., Mitler M. M., Roth T., Westbrook P. R., Keenan S. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep. 1986 Dec;9(4):519–524. doi: 10.1093/sleep/9.4.519. [DOI] [PubMed] [Google Scholar]
  5. Elliott M. W., Aquilina R., Green M., Moxham J., Simonds A. K. A comparison of different modes of noninvasive ventilatory support: effects on ventilation and inspiratory muscle effort. Anaesthesia. 1994 Apr;49(4):279–283. doi: 10.1111/j.1365-2044.1994.tb14173.x. [DOI] [PubMed] [Google Scholar]
  6. Ellis E. R., Bye P. T., Bruderer J. W., Sullivan C. E. Treatment of respiratory failure during sleep in patients with neuromuscular disease. Positive-pressure ventilation through a nose mask. Am Rev Respir Dis. 1987 Jan;135(1):148–152. doi: 10.1164/arrd.1987.135.1.148. [DOI] [PubMed] [Google Scholar]
  7. Ferguson G. T., Gilmartin M. CO2 rebreathing during BiPAP ventilatory assistance. Am J Respir Crit Care Med. 1995 Apr;151(4):1126–1135. doi: 10.1164/ajrccm/151.4.1126. [DOI] [PubMed] [Google Scholar]
  8. Johns M. W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991 Dec;14(6):540–545. doi: 10.1093/sleep/14.6.540. [DOI] [PubMed] [Google Scholar]
  9. Johns M. W. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep. 1992 Aug;15(4):376–381. doi: 10.1093/sleep/15.4.376. [DOI] [PubMed] [Google Scholar]
  10. Kerby G. R., Mayer L. S., Pingleton S. K. Nocturnal positive pressure ventilation via nasal mask. Am Rev Respir Dis. 1987 Mar;135(3):738–740. doi: 10.1164/arrd.1987.135.3.738. [DOI] [PubMed] [Google Scholar]
  11. Labanowski M., Schmidt-Nowara W., Guilleminault C. Sleep and neuromuscular disease: frequency of sleep-disordered breathing in a neuromuscular disease clinic population. Neurology. 1996 Nov;47(5):1173–1180. doi: 10.1212/wnl.47.5.1173. [DOI] [PubMed] [Google Scholar]
  12. Leger P., Bedicam J. M., Cornette A., Reybet-Degat O., Langevin B., Polu J. M., Jeannin L., Robert D. Nasal intermittent positive pressure ventilation. Long-term follow-up in patients with severe chronic respiratory insufficiency. Chest. 1994 Jan;105(1):100–105. doi: 10.1378/chest.105.1.100. [DOI] [PubMed] [Google Scholar]
  13. Meecham Jones D. J., Wedzicha J. A. Comparison of pressure and volume preset nasal ventilator systems in stable chronic respiratory failure. Eur Respir J. 1993 Jul;6(7):1060–1064. [PubMed] [Google Scholar]
  14. Restrick L. J., Fox N. C., Braid G., Ward E. M., Paul E. A., Wedzicha J. A. Comparison of nasal pressure support ventilation with nasal intermittent positive pressure ventilation in patients with nocturnal hypoventilation. Eur Respir J. 1993 Mar;6(3):364–370. [PubMed] [Google Scholar]
  15. van den Hoed J., Kraemer H., Guilleminault C., Zarcone V. P., Jr, Miles L. E., Dement W. C., Mitler M. M. Disorders of excessive daytime somnolence: polygraphic and clinical data for 100 patients. Sleep. 1981;4(1):23–37. doi: 10.1093/sleep/4.1.23. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES